A case of etomidate use in management of adrenocortical carcinoma with hypercortisolemia

A case of etomidate use in management of adrenocortical carcinoma with hypercortisolemia

Show other versions (1)

Adrenocortical carcinoma (ACC) is rare with an incidence of 0.7-2.0 per million per year. Approximately 60% of cases present with hy-percortisolism, and rapidly progressing Cushing’s syndrome with or without virilisation is the most frequent presentation of ACC. Surgical intervention, aimed at remov...

Full description

Bibliographic Details
Main Authors: Chacko, C. (Author), Daly, R. (Author), Hatta, S.F.W.M (Author), Raghavan, R. (Author)
Format: Article
Language:English
Published: Elmer Press, 2020
Subjects:
Adrenocortical carcinoma
Cushing’s syndrome
Etomidate
Hyper-cortisolemia
Young hypertension
Online Access:View Fulltext in Publisher
View in Scopus

Similar Items

Similar Items